Insilico Medicine at 42nd Annual J.P. Morgan Healthcare Conference (IMAGE)
Caption
Representatives who will be onsite for the event include Insilico founder and CEO Alex Zhavoronkov, PhD; Chief Business Officer Michelle Chen, PhD; Petrina Kamya, PhD, Global Head of AI Platforms and President of Insilico Medicine Canada; Chief Medical Officer Sujata Rao, MD; Jue Wang, PhD, Head of Business Development, APAC; and Sean Cullen, PhD, Associate Director of Business Development.
Credit
Insilico Medicine
Usage Restrictions
none
License
Original content